Skip to main navigation Skip to search Skip to main content

One-year antibody persistence and safety of a 4-dose schedule of menacwy-crm in healthy infants from South Korea

Research output: Contribution to journalJournal articlepeer-review

Original languageKorean
JournalClinical and Experimental Vaccine Research
StatePublished - 2019.07.1

Cite this